Cell Mediated Immunity on Urologic Tumor Using Delayed Cutaneous Hypersensitivity.
- Author:
Chul Soo YOON
1
;
Kap Byung KIM
;
Hyun Yul RHEW
Author Information
1. Kosin Medical College, Pusan, Korea.
- Publication Type:Original Article
- Keywords:
cell mediated immunity;
urologic tumor
- MeSH:
Adolescent;
Female;
Humans;
Hypersensitivity*;
Immunity, Cellular*;
Incidence;
Male;
Prognosis;
Tetanus;
Tuberculin;
Urology
- From:Korean Journal of Urology
1989;30(3):307-313
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Delayed cutaneous hypersensitivity test had been demonstrated to correlate inversely with stage of disease and predict prognosis of tumor. We evaluated the delayed cutaneous hypersensitivity(D.C.H.) with Multitest CMI between the tumor group and normal control group in Department of Urology, Kosin, Medical College Hospital during the period from October 1986 to August 1988. The result were as follows: 1. D.C.H. with Multitest CMI was compared between the normal control and tumor group: mean total score of positive antigens was markedly decreased in the tumor group(11.3mm for tumor, 15.9mm for control p<0.01) and average number of positive reaction was also decreased in the tumor group(2.6 for tumor, 4.2 for control p<0.01). 2. The percentages of energic response were 11.9% for tumor and 0% for control and the incidence of hypoenergy was also increased in the tumor group (34.2% for tumor, 9% for control). 3. The percentages of Warning score were 27.6% for tumor and 6.8% for control. 4. In comparison with each antigens, there were the strongest reaction and the highest reaction with tuberculin in both group (98.3% for control, 82.9% for tumor) while the weakest reaction with tetanus (16.3% for control, 3.9% for tumor). 5. In comparison of D.C.H. between male and female, low cell mediated immunity was observed in female for the average number of positive antigens in control(4.8 for male, 3.7 for female) and for the average store of in tumor (11.7 mm for male, 9.6 mm for female). 6. In D.C.H. between age groups in control, the youth (17-25 years old) showed the strongest reaction (mean total score 19.1 mm) and 26-65 years old group had relatively stable immunity.
